Bauersfeld Paul
Transaction: 12/31/2025
BUY
Change
+100,000
Price
$1.10
Filing
01/02/2026
Type
BUY


Quantitative profile — not an investment recommendation.
Key valuation, quality, financial strength, momentum and analyst data.
How strong this company looks for long-term investors
Recent executive and insider activity
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Bauersfeld Paul | BUY | +100,000 | $1.10 | 12/31/2025 | 01/02/2026 |
| Booker Stuart Byron | BUY | +50,000 | $1.10 | 12/31/2025 | 01/02/2026 |
| Julia Dean L. | BUY | +350,000 | $1.10 | 12/31/2025 | 01/02/2026 |
| Knight Nate | BUY | +50,000 | $1.10 | 12/31/2025 | 01/02/2026 |
| McDonnell Sean | BUY | +100,000 | $1.10 | 12/31/2025 | 01/02/2026 |
| Provost Anne Schmidt | BUY | +50,000 | $1.10 | 12/31/2025 | 01/02/2026 |
| Salkind Gene | BUY | +250,000 | $1.10 | 12/31/2025 | 01/02/2026 |
| Trepeta Sean | BUY | +100,000 | $1.10 | 12/31/2025 | 01/02/2026 |
| Salkind Gene | BUY | +100,000 | $1.00 | 09/15/2025 | 09/19/2025 |
| Salkind Gene | BUY | +25,000 | $1.00 | 09/15/2025 | 09/19/2025 |
| Salkind Gene | SELL | -210,000 | $0.50 | 12/30/2024 | 01/02/2025 |
| Salkind Gene | BUY | +420,000 | $0.50 | 12/30/2024 | 01/02/2025 |
| Booker Stuart Byron | BUY | +50,000 | $2.45 | 10/08/2024 | 10/21/2024 |
| Salkind Gene | BUY | +250,000 | $2.45 | 10/08/2024 | 10/21/2024 |
| Trepeta Sean | BUY | +100,000 | $2.45 | 10/08/2024 | 10/21/2024 |
| McDonnell Sean | BUY | +50,000 | $2.45 | 10/08/2024 | 10/21/2024 |
| Knight Nate | BUY | +50,000 | $2.45 | 10/08/2024 | 10/21/2024 |
| Provost Anne Schmidt | BUY | +50,000 | $2.45 | 10/08/2024 | 10/21/2024 |
| Julia Dean L. | BUY | +450,000 | $2.45 | 10/08/2024 | 10/21/2024 |
| Bauersfeld Paul | BUY | +150,000 | $2.45 | 10/08/2024 | 10/21/2024 |